Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10463618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delivery of molecular and cellular medicine to solid tumors.

  1998cited by this paper
• Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.

  1998cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998influential reference
• Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

  1998cited by this paper
• The next frontier of molecular medicine: Delivery of therapeutics

  1998cited by this paper
• Tumor induction of VEGF promoter activity in stromal cells.

  1998cited by this paper
• Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.

  1998cited by this paper
• Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.

  1997cited by this paper
• Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.

  1997cited by this paper
• The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors.

  1997cited by this paper
• Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation

  1997cited by this paper
• Neovasculature induced by vascular endothelial growth factor is fenestrated.

  1997cited by this paper
• Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189.

  1997cited by this paper
• The biology of vascular endothelial growth factor.

  1997influential reference
• Quantitative angiogenesis assays: Progress and problems

  1997cited by this paper
• Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

  1996cited by this paper
• Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin

  1996cited by this paper
• Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

  1996cited by this paper
• Delivery of Molecular Medicine to Solid Tumors

  1996cited by this paper
• Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.

  1996cited by this paper
• Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow

  1996cited by this paper
• Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

  1995cited by this paper
• Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium.

  1995cited by this paper
• Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.

  1995cited by this paper
• Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

  1995influential reference
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain.

  1995cited by this paper
• Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows.

  1994cited by this paper
• Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

  1994cited by this paper
• Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms

  1994cited by this paper
• Endothelial actin cytoskeleton in rat mesentery microvasculature.

  1994cited by this paper
• Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?

  1994cited by this paper
• Vascular permeability factor, tumor angiogenesis and stroma generation.

  1994cited by this paper
• Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

  1994cited by this paper
• Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.

  1993cited by this paper
• Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice.

  1993cited by this paper
• A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.

  1993cited by this paper
• Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.

  1992cited by this paper
• Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.

  1992cited by this paper
• Antigenic heterogeneity of vascular endothelium.

  1992cited by this paper
• Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

  1991cited by this paper
• Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor

  1991cited by this paper
• Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

  1991cited by this paper
• Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

  1989cited by this paper
• Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

  1988cited by this paper
• Microvascular permeability of normal and neoplastic tissues.

  1986cited by this paper
• Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

  1983cited by this paper
• Temperature gradients and local perfusion in a mammary carcinoma.

  1982cited by this paper
• Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.

  1979cited by this paper
• Landis Award Lecture. The myogenic response and the microcirculation.

  1977cited by this paper

• Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

  2025cites this paper
• Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia

  2025cites this paper
• Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery

  2025cites this paper
• Achieving cell-type selectivity in metabolic oligosaccharide engineering

  2025cites this paper
• Bone marrow vessels are hyperpermeable to macromolecules and nanoscale medicine in a size-dependent manner.

  2025cites this paper
• Improving Tumor Targeting and Penetration for Nanoparticle‐Mediated Cancer Therapy

  2025cites this paper
• Pathological angiogenesis was associated with cerebrovascular lesion and neurodegeneration in Alzheimer's disease

  2025cites this paper
• Prospect of extracellular vesicles in tumor immunotherapy

  2025cites this paper
• Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers

  2024cites this paper
• Application of Nano-Delivery System in Tumor Immunotherapy

  2023cites this paper
• TEMPI syndrome: A clinical, light‐microscopic and phenotypic evaluation with review of the literature

  2023cites this paper
• Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics.

  2023cites this paper
• Advances in nuclei targeted delivery of nanoparticles for the management of cancer.

  2023cites this paper
• Lipid‐, Inorganic‐, Polymer‐, and DNA‐Based Nanocarriers for Delivery of the CRISPR/Cas9 system

  2023cites this paper
• PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities via Passive Extravasation across "Leaky" Endothelium.

  2022cites this paper
• Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors.

  2022cites this paper
• Externally Triggered Drug Delivery Techniques Using Micro and Nanoparticles

  2022cites this paper
• Effective Anticancer Therapy by Combination of Nanoparticles Encapsulating Chemotherapeutic Agents and Weak Electric Current.

  2022cites this paper
• Progress and Hurdles of Therapeutic Nanosystems against Cancer

  2022cites this paper
• Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research

  2022cites this paper
• Integrin‐Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor‐Specific Delivery Achieve MYCN Silencing with Improved Survival

  2021cites this paper
• Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model

  2021cites this paper
• Apoptosis modulating nanochemotherapeutics in the treatment of cancer: Recent progress and advances

  2021cites this paper
• A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy

  2021cites this paper
• Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label.

  2021cites this paper
• Lipid Cubic Systems for Sustained and Controlled Delivery of Antihistamine Drugs

  2021cites this paper
• Dilation of Brain Veins and Perivascular Infiltration by Glioblastoma Cells in an In Vivo Assay of Early Tumor Angiogenesis

  2021cites this paper
• Rap1 Small GTPase Regulates Vascular Endothelial-Cadherin-Mediated Endothelial Cell-Cell Junctions and Vascular Permeability.

  2021cites this paper
• Manipulating dynamic tumor vessel permeability to enhance polymeric micelle accumulation.

  2020cites this paper
• The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases

  2020cites this paper
• Tumor‐derived microparticles in tumor immunology and immunotherapy

  2020cites this paper
• Analysis of Melanoma Secretome for Factors That Directly Disrupt the Barrier Integrity of Brain Endothelial Cells

  2020cites this paper
• Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective

  2020cites this paper
• Nafion-Based Nanocarriers for Fluorine Magnetic Resonance Imaging

  2020cites this paper
• Nafion® based nanocarriers for 19F-MR Imaging.

  2020cites this paper
• Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease

  2020cites this paper
• Drug delivery in tumors is enhanced by bacterial proteolytic activity in a size, pharmacokinetic, and binding affinity dependent manner - A mechanistic understanding.

  2020cites this paper
• Tumor Microenvironment

  2020cites this paper
• Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.

  2020cites this paper
• Enhancement of tumour penetration by nanomedicines through strategies based on transport processes and barriers.

  2020cites this paper
• Magnetic polymeric nanobubbles with optimized core size for MRI/ultrasound bimodal molecular imaging of prostate cancer.

  2020cites this paper
• TMTP1-modified Indocyanine Green-loaded Polymeric Micelles for Targeted Imaging of Cervical Cancer and Metastasis Sentinel Lymph Node in vivo

  2019cites this paper
• Engineered materials for in vivo delivery of genome-editing machinery

  2019cites this paper
• Biological barriers to cancer drug delivery, efficacy and cancer models

  2019cites this paper
• GPIHBP1 expression in gliomas promotes utilization of lipoprotein-derived nutrients

  2019cites this paper
• Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation

  2019cites this paper
• Analysis of chemotherapeutic-induced tumor dormancy in Glioblastoma Multiforme and alternative therapy approaches

  2019cites this paper
• Contrast-Enhanced T1-Weighted Digital Subtraction for Increased Lesion Conspicuity and Quantifying Treatment Response in Malignant Gliomas

  2019cites this paper
• A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

  2019cites this paper
• Drug delivery in tumors is enhanced by bacterial proteolytic activity in a size and binding affinity dependent manner -A mechanistic understanding

  2019cites this paper
• The Application of Biomaterials in the Treatment of Platinum‐Resistant Ovarian Cancer

  2019cites this paper
• Identifying macrophage enrichment in atherosclerotic plaques by targeting dual-modal US imaging/MRI based on biodegradable Fe-doped hollow silica nanospheres conjugated with anti-CD68 antibody.

  2018cites this paper
• Cancer-targeted reactive oxygen species-degradable polymer nanoparticles for near infrared light-induced drug release.

  2018cites this paper
• Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends

  2018cites this paper
• Low‐power and low‐drug‐dose photodynamic chemotherapy via the breakdown of tumor‐targeted micelles by reactive oxygen species

  2018cites this paper
• Intravitreal aflibercept: its role in treatment of neovascular age-related macular degeneration

  2018cites this paper
• Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.

  2018cites this paper
• Interaction of Nanomaterials with Biological Systems

  2018cites this paper
• Effect of orientational ordering of magnetic nanoemulsions immobilized in agar gel on magnetic hyperthermia

  2018cites this paper
• Tuneable chitosan particles with potential forensic and pharmaceutical applications

  2018cites this paper
• Long‐term regulation of gene expression in muscle cells by systemically delivered siRNA

  2017cites this paper
• Strategies for improving drug delivery: nanocarriers and microenvironmental priming

  2017cites this paper
• Multifunctional Surface Modification: Facile and Flexible Reactivity toward a Precisely Controlled Biointerface.

  2017cites this paper
• Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

  2017influential citation
• Anti-angiogenic efficacy of Bevacizumab alone and in combination with a dual PI3K/mTOR inhibitor in an orthotopic model of malignant glioma: A multimodal neuro-imaging approach

  2017cites this paper
• Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

  2017cites this paper
• Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.

  2017cites this paper
• EGFR‐targeted micelles containing near‐infrared dye for enhanced photothermal therapy in colorectal cancer

  2017cites this paper
• Protein corona composition of functionalised and loaded silica nanoparticles formed in foetal calf serum

  2017cites this paper
• Quantitative and correlative biodistribution analysis of 89Zr-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing mice.

  2017cites this paper
• Liberación controlada de principios activos mediante el empleo de formulaciones galénicas

  2017cites this paper
• A Look at the Pharmaceutical Industry in Belgium

  2017cites this paper
• Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions

  2017cites this paper
• Lymph node effective vascular permeability and chemotherapy uptake

  2017cites this paper
• Improving chemotherapy drug delivery by nanoprecision tools

  2017cites this paper
• The interaction of clozapine loaded nanocapsules with the hCMEC/D3 cells - In vitro model of blood brain barrier.

  2017cites this paper
• Magnetic hyperthermia in magnetic nanoemulsions: Effects of polydispersity, particle concentration and medium viscosity

  2017cites this paper
• Research report 2016

  2017cites this paper
• Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.

  2017cites this paper
• BQ123 selectively improved tumor perfusion and enhanced nanomedicine delivery for glioblastomas treatment

  2017cites this paper
• 3-Helix Micelles as Nanocarriers – Understanding Hierarchical Structures, Kinetic Pathway, and Controlling Multivalency

  2016cites this paper
• Measuring Vascular Permeability In Vivo.

  2016cites this paper
• Synthesis of Ferromagnetic Fe0.6Mn0.4O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1‐T2 Dual‐Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy

  2016cites this paper
• Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery

  2016cites this paper
• Post isolation modification of exosomes for nanomedicine applications.

  2016cites this paper
• Preparation and Evaluation of Oxaliplatin Thermosensitive Liposomes with Rapid Release and High Stability

  2016cites this paper
• Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.

  2016cites this paper
• Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability

  2016cites this paper
• Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors

  2016cites this paper
• In Vivo FRET Imaging of Tumor Endothelial Cells Highlights a Role of Low PKA Activity in Vascular Hyperpermeability.

  2016cites this paper
• Ultrasound ablation enhances drug accumulation and survival in mammary carcinoma models.

  2016cites this paper
• Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

  2016cites this paper
• Novel Antibody-Targeted Liposomes for the Treatment of Solid Tumors

  2016cites this paper
• Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing

  2016cites this paper
• Multifunctional Polymeric Micelles Co-loaded with Anti–Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer

  2015cites this paper
• Plasmid pOrF-hTrail targeting to glioma using transferrin-modified polyamidoamine dendrimer

  2015cites this paper
• Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.

  2015cites this paper
• Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines

  2015cites this paper
• Nanomedicines for Endothelial Disorders.

  2015cites this paper
• Plasmid pOrF-hTrail targeting to glioma using transferrin-modified polyamidoamine dendrimer

  2015cites this paper